Page last updated: 2024-11-02

oxophenylarsine and Amyotrophic Lateral Sclerosis

oxophenylarsine has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moreno-Ortega, AJ1
Al-Achbili, LM1
Alonso, E1
de Los Ríos, C1
García, AG1
Ruiz-Nuño, A1
Cano-Abad, MF1

Other Studies

1 other study available for oxophenylarsine and Amyotrophic Lateral Sclerosis

ArticleYear
Neuroprotective Effect of the Novel Compound ITH33/IQM9.21 Against Oxidative Stress and Na(+) and Ca(2+) Overload in Motor Neuron-like NSC-34 Cells.
    Neurotoxicity research, 2016, Volume: 30, Issue:3

    Topics: Amyotrophic Lateral Sclerosis; Animals; Arsenicals; Benzamides; Calbindin 1; Calcium; Cell Survival;

2016